Due for re-check: the scheduled review date of 2026-09-11 has passed. Every value below still carries the source it was taken from and the passage that states it — check it against the link.
0641-6052-25 · Meperidine Hydrochloride Injection · Hikma Pharmaceuticals USA, Inc.
What is the package ndc for 0641-6052-25 · Meperidine Hydrochloride Injection · Hikma Pharmaceuticals USA, Inc.?
For 0641-6052-25 · Meperidine Hydrochloride Injection · Hikma Pharmaceuticals USA, Inc., package ndc is 0641-6052-25; generic name is Meperidine Hydrochloride Injection; manufacturer is Hikma Pharmaceuticals USA, Inc; status is Current; availability now is Available, recorded from its source on 2026-09-01; source re-checked 2026-09-08.
"initial_posting_date": "05/30/2025", "package_ndc": "0641-6052-25", "generic_name": "Meperidine Hydrochloride Injection", "contact_info": "800-631-2174", "availability": "Available", "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released."
— api.fda.gov, retrieved 2026-09-01
- Package NDC
- 0641-6052-25 verified
- Generic name
- Meperidine Hydrochloride Injection verified
- Manufacturer
- Hikma Pharmaceuticals USA, Inc. verified
- Status
- Current verified
- Availability now
- Available verified
- FDA note
- Additional lots are scheduled to be manufactured. Product will be made available as it is released. verified
- Initial posting date
- 05/30/2025 verified
- Last update date
- 08/13/2026 verified
- Days in shortage
- 459 our reading
- Dosage form
- Injection verified
- Therapeutic category
- Analgesia/Addiction verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Manufacturer, Status, Last update date, Dosage form and Therapeutic category
"update_date": "08/13/2026", "therapeutic_category": [ "Analgesia/Addiction" ], "dosage_form": "Injection", "presentation": "Meperidine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-6052-25)", "company_name": "Hikma Pharmaceuticals USA, Inc.", "status": "Current"
— all from api.fda.gov, retrieved 2026-09-01
Source
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Meperidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000